BML-210
| CAS No. | 537034-17-6 | Cat. No. | BCP16850 |
| Name | BML-210 | ||
| Synonyms | BML 210;BML210; | ||
| Formula | C20H25N3O2 | M. Wt | 339.43 |
| Description | Cell cycle analysis indicated that HeLa cell treatment with 20 and 30 μM concentration of BML-210 increased the proportion of cells in G0/G1 phase, and caused accumulation in subG1, indicating that the cells are undergoing apoptosis. BML-210 inhibits the growth of NB4 cells in dose- and time-dependent manner. | ||
| Pathways | Cell Cycle/DNA Damage Epigenetics | ||
| Targets | HDAC | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.